Showing: 1 - 2 of 2 RESULTS

Prescription Savings Apps Help Medicine Go Down

There’s no field of commercial medicine that’s been more impacted by the digital shift than … medicine itself. Proliferation of Rx savings apps shows a consumer belief in better living through smartphones, starting with the controversial price of the prescription drugs.

PYMNTS inaugural Provider Ranking of Prescription Apps gives the lay of the land as we enter Q4 2020 dealing with a plague, a recession and a contentious election simultaneously. Might as well watch the skies for flaming asteroids too at this point. But at least prescriptions will cost less.

The Top 5

Topping the charts at No. 1 is GoodRx, the telemedicine drug price tracker that went public in September. At No. 2 is RxSaver from RetailMeNot, with No. 3 ranked app SingleCare working directly with pharmacies on discounts. No. 4 on the inaugural Provider Ranking of Prescription Apps is OptumRx with its user base of some 65 million consumers. Finishing out the Top 5 at No. 5 is a familiar name, CVS Caremark, the huge prescription benefit management operation.

The Top 10

We love the Top 10 because it’s where you find sleeping giants and energetic chart-climbers.

Take, for example, KrogerRxSC at No. 6 this month with its popular membership-based Rx discount program, with another grocery powerhouse app, Publix Pharmacy, flexing its buying power, foot traffic and consumer affinity. At No. 8 is the Express Scripts app from the eponymous pharmacy benefit management outfit. At No. 9 in this Provider Ranking of Prescription Apps is Rx Local, with Prescription Rx Discount Card RxApp landing No. 10.

——————————

NEW PYMNTS DATA: HOW WE SHOP – SEPTEMBER 2020 

The How We Shop Report, a PYMNTS collaboration with PayPal, aims to understand how consumers of all ages and incomes are shifting to shopping and paying online in the midst of the COVID-19 pandemic. Our research builds on a series of studies conducted since March, surveying more than 16,000 consumers on how their shopping habits and payments preferences are changing as the crisis continues. This report focuses on our latest survey of 2,163 respondents and examines how their increased appetite for online commerce and digital touchless methods, such as QR codes, contactless cards and digital wallets, is poised to shape the post-pandemic economy.

Source Article

M Health Fairview Applauds PreferredOne as First in Minnesota to Cover Innovative Prescription Digital Therapeutics to Treat Addiction

Largest Minnesota health system urging others to cover the FDA-authorized treatments

PreferredOne, Fairview’s health benefits management company, is the first health insurance provider in Minnesota to cover two innovative prescription digital therapeutics (PDTs) to treat addiction: reSET® and reSET-O®, which are manufactured by Pear Therapeutics, Inc. The software-based treatments are authorized by the U.S. Food and Drug Administration (FDA) and are indicated to treat substance use disorder and opioid use disorder, respectively.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200930005985/en/

PreferredOne, Fairview’s health benefits management company, is the first health insurance provider in Minnesota to cover two FDA-approved prescription digital therapeutics to treat addiction. (Provided by Pear Therapeutics)

reSET and reSET-O are the first two PDTs to receive market authorization to treat disease from FDA. PDTs are apps that are downloaded to a patient’s mobile device after being prescribed. Both products, which are adjunctive to outpatient counselling, provide patients with algorithm-driven cognitive behavioral therapy, fluency training, and contingency management, while clinicians receive access to clinical dashboards to inform in-office and tele visits. reSET is used as a monotherapy and reSET-O is used in combination with transmucosal buprenorphine.

“M Health Fairview is committed to ensuring our patients have coverage for these innovative mental health resources, and we’re excited that PreferredOne is leading the way in Minnesota by offering these products,” said Beth Heinz, executive of mental health and addiction services for M Health Fairview. “The only way to ensure broad access is for other payors to join us in reimbursing these products. Patients in all systems will benefit when more providers join this effort and enable physicians to prescribe these solutions.”

The COVID-19 pandemic arrived amid an ongoing addiction crisis, and it exacerbated health issues for many Minnesotans. Only 1 in 10 people with a substance use disorder receive treatment in the U.S., according to the Minnesota Department of Health.

“We applaud PreferredOne and M Health Fairview’s commitment to addiction and mental health coverage,” said Corey McCann, M.D., Ph.D., President and CEO of Pear Therapeutics. “Now, more than ever, people struggling with substance use disorders need access to recovery support and treatment due to the impact of the pandemic. Together we can address this unmet need, and we hope that other health plans in Minnesota will join in taking this step to ensure access to innovative evidence-based therapeutics for all Minnesotans.”

About M Health Fairview

M Health Fairview is the newly expanded collaboration between the University of Minnesota, University of Minnesota Physicians, and Fairview Health Services. The healthcare system combines the best of academic and community medicine – expanding access to world-class, breakthrough care through our 10 hospitals and 60 clinics.

About PreferredOne

PreferredOne, a wholly-owned subsidiary of Fairview Health Services, leads the market with products and services that conserve employer health plan dollars while helping more than 364,000 members achieve their best health. Comprehensive local and national provider networks together with an emphasis on health care cost and quality maximize the value of employee health